Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease and Diabetic Nephropathy: A Single Center Experience.
10.3904/kjim.2007.22.3.139
- Author:
Ki Sun BAE
1
;
Hyeong Cheon PARK
;
Byung Seung KANG
;
Jong Won PARK
;
Nu Ri CHON
;
Kyung Jin OH
;
Young Won YOON
;
You Sun HONG
;
Sung Kyu HA
Author Information
1. Department of Internal Medicine, Yongdong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Hask1951@yumc.yonsei.ac.kr
- Publication Type:Original Article ; Comparative Study
- Keywords:
Diabetic Nephropathy;
Coronary Artery Disease;
Coronary Artery Bypass Grafting;
Percutaneous Transluminal Coronary Angioplasty
- MeSH:
Aged;
*Angioplasty, Transluminal, Percutaneous Coronary/adverse effects;
*Coronary Artery Bypass/adverse effects;
Coronary Artery Disease/complications/surgery/*therapy;
*Diabetic Nephropathies/complications;
Female;
Humans;
Male;
Middle Aged;
Retrospective Studies;
Severity of Illness Index;
Survival Analysis;
Treatment Outcome
- From:The Korean Journal of Internal Medicine
2007;22(3):139-146
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Patients with diabetic nephropathy (DN) and coronary artery disease (CAD) represent a subset of patients with high cardiovascular morbidity and mortality. The optimal revascularization strategy using either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) remains controversial. The purpose of this study was to compare the clinical outcomes of PCI to CABG in DN patients with CAD. METHODS: The clinical and angiographic records of DN patients with CAD who underwent either CABG (n=52) or PCI (n=48) were retrospectively analyzed. RESULTS: The baseline characteristics were similar in the two groups except for the severity of the CAD. At 30 days, the death rate (PCI: 2.1% vs. CABG: 9.6%, p=0.21) and major adverse cardiac events (MACE) rate (PCI: 2.1 % vs. CABG: 9.6%, p=0.21) were similar in comparisons between the PCI and CABG groups. At three years, the death rate (PCI: 18.8% vs. CABG: 19.2%, p=0.94) was similar between the PCI and CABG groups but the MACE rate (PCI: 47.9% vs. CABG: 21.2%, p=0.006) was higher in the PCI group compared to the CABG group. In addition, the repeat revascularization rate was higher in the PCI group compared to the CABG group (PCI: 12.5% vs. CABG: 1.9%, p=0.046). CONCLUSIONS: The CABG procedure was associated with a lower incidence of MACE and repeat revascularization for up to three years of follow-up in DN patients with CAD. However, the overall survival rate was similar in the CABG and PCI groups. Therefore, CABG may be superior to PCI with regard to MACE and repeat revascularization.
